# Everest Group, Ltd. (EG)

> Source: Nexqual · https://nexqual.com/EG · data as of 2026-10-22 20:00 UTC · cite as "Nexqual, Everest Group, Ltd. (EG), nexqual.com/EG" · informational, not investment advice.

**Price:** USD 407.56 (+3.24% on the day) · last close of Oct 22, 2026; US market pre market, not a live price. Prev close 394.78 · day 396.67–408.11 · 52w 302.44–408.11 · market cap $15.6B · NYQ

## Key facts
- Last four reported quarters (through Jun 30, 2026): revenue $16.8B, net income $1.91B (11.4% margin) (SEC filings).
- Valuation: P/E 8.2x (avg 8.7x at the last 3 fiscal year-ends).
- 4 of 80 tracked superinvestors hold EG (13F, Q2 2026): 0 new, 1 added, 3 reduced, 0 unchanged.
- Insider open-market sales, last ~7 months: 1 Form 4 filings, $273K; 1 not under a Rule 10b5-1 plan ($273K); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
- Analysts: Buy (mean 2.35 on a 1–5 scale) (17 analysts), mean target USD 409.81 (range 368–489).
- Total return with dividends: 1Y +18.8% vs S&P 500 +14.9%; 5Y +59.7% vs S&P 500 +80.3%.
- Next earnings: 2026-10-28, EPS estimate USD 8.16, revenue estimate $3.03B.

## Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $11.9B | $12.1B | $14.6B | $17.3B | $17.5B | $16.8B |
| Net income | $1.38B | $597M | $2.52B | $1.37B | $1.59B | $1.91B |
| EPS (diluted) | $34.62 | $15.19 | $60.19 | $31.78 | $37.80 | — |
| Net margin | 11.6% | 5.0% | 17.3% | 7.9% | 9.1% | 11.4% |
| Revenue growth | +23.6% | +1.6% | +21.0% | +18.5% | +1.2% | — |
| Cash + short-term investments | $375M | $283M | $308M | $331M | — | — |
Fiscal years end Dec. EPS is split-adjusted.

## Valuation (price ÷ last four quarters, through Jun 30, 2026)
P/E 8.2x · P/S 0.9x · P/B 1.0x · Earnings yield 12.24% · Dividend yield (paid, TTM) 2.07% · Buyback yield (TTM) 7.18%
P/E at fiscal year-ends: Dec 2025 8.9x, Dec 2024 11.3x, Dec 2023 5.8x.

## Superinvestors (SEC 13F-HR, Q2 2026)
4 of 80 tracked investors hold EG. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Vulcan Value Partners |  | 11.28% | $370M | Reduced -23.9% |
| Sarah Ketterer | Causeway Capital Management | 0.98% | $90.3M | Added +1.1% |
| Christopher Davis | Davis Advisors | 0.19% | $45.2M | Reduced -10.3% |
| Van Den Berg Management I |  | 0.06% | $294K | Reduced -24.0% |

## Insider sales (SEC Form 4, open-market, last ~7 months)
0 of 1 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.
| Trade date | Insider | Role | Shares | Value | % of holdings sold | 10b5-1 plan | Insider type |
|---|---|---|---|---|---|---|---|
| 2026-05-07 | Keen Jason | EVP & CEO of GW & S Division | 775 | $273K | 8.7% | No | Too little history (no open-market trades in 2023–2025) |
% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).
Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

## Analysts
Consensus Buy (mean 2.35 on a 1–5 scale), 17 analysts; mean target USD 409.81 (low 368, high 489).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-12 | Keefe, Bruyette & Woods | Target lowered | Outperform | $414 → $407 |
| 2026-10-07 | Mizuho | Target lowered | Neutral | $416 → $398 |
| 2026-09-22 | RBC Capital | Initiated | Outperform | $455 |
| 2026-08-19 | TD Cowen | Target raised | Hold | $365 → $385 |
| 2026-08-03 | UBS | Target raised | Neutral | $374 → $395 |
| 2026-07-31 | Citigroup | Target raised | Neutral | $395 → $415 |
| 2026-07-31 | Mizuho | Target lowered | Neutral | $418 → $416 |
| 2026-07-31 | Wells Fargo | Target raised | Equal-Weight | $373 → $396 |
| 2026-07-30 | Evercore ISI Group | Target raised | In-Line | $375 → $377 |
| 2026-07-30 | Barclays | Target raised | Overweight | $420 → $430 |
| 2026-07-10 | Evercore ISI Group | Target raised | In-Line | $365 → $375 |
| 2026-07-09 | Wells Fargo | Target raised | Equal-Weight | $356 → $373 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-23) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +18.8% | +59.7% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +18.8% | +9.8% |
| Volatility (annualized) | 24.3% | 24.4% |
| Max drawdown | -12.7% (Oct 2025→Oct 2025) | -22.6% (Sep 2024→Dec 2025) |

## Peers (Insurance - Reinsurance)
RNR (RenaissanceRe Holdings Ltd.) USD 362.59 +2.12% · RGA (Reinsurance Group of America, I) USD 272.05 +1.07% · HG (Hamilton Insurance Group, Ltd.) USD 37.11 +1.62% · SPNT (SiriusPoint Ltd.) USD 25.96 +1.09% · GLRE (Greenlight Reinsurance, Ltd.) USD 15.3 +2.41%

## More
Full page: https://nexqual.com/EG · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Supply chain and relationships (SEC annual reports)

Named in EG's own 10-K filed 2026-02-26 (https://www.sec.gov/Archives/edgar/data/1095073/000109507326000006/eg-20251231.htm):

| Relationship | Company | Sentence in the filing |
|---|---|---|
| Partner | AMERICAN INTERNATIONAL GROUP, INC. (AIG) | "On October 26, 2025, the Company entered into an agreement with American International Group, Inc. ("AIG") to sell the renewal rights for certain lines of commercial retail insurance business written by the Company in th…" |

## Analyst estimates and revisions

| Period | EPS est. | 90d ago | Change | Revenue est. | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends 2026-09-30) | $8.16 | $8.45 | -3.4% | $3.03B | 15 |
| Next quarter (ends 2026-12-31) | $13.44 | $13.07 | +2.9% | $3.11B | 14 |
| Current fiscal year (ends 2026-12-31) | $54.48 | $52.44 | +3.9% | $12.37B | 15 |
| Next fiscal year (ends 2027-12-31) | $60.14 | $60.45 | -0.5% | $11.80B | 15 |

## Options: expected move (Cboe, 15-min delayed)

Expected move by 2026-11-20 (includes earnings 2026-10-28): ±6.8%; last 8 reports averaged ±4%.

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-11-20 | 28 | 29.3% | ±6.8% |
| 2026-12-18 | 56 | 25.0% | ±7.9% |
| 2027-01-15 | 84 | 23.3% | ±9.0% |
| 2027-04-16 | 175 | 23.2% | ±12.8% |
| 2027-05-21 | 210 | 24.0% | ±14.6% |